GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 19 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | -92.3% | 100 | -96.0% | 0.00% | – |
| Q1 2018 | $13,000 | +225.0% | 2,500 | +172.9% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 916 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 916 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -28.6% | 916 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 916 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | +75.0% | 916 | +120.2% | 0.00% | – |
| Q2 2015 | $4,000 | – | 416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |